KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Assets (2019 - 2025)

Castle Biosciences' Return on Assets history spans 7 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Assets fell 8.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, down 8.0%, while the annual FY2025 figure was 0.04%, 8.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.04% at Castle Biosciences, down from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.03% in Q4 2024 and bottomed at 0.21% in Q2 2023.
  • The 5-year median for Return on Assets is 0.07% (2024), against an average of 0.08%.
  • The largest annual shift saw Return on Assets fell -10bps in 2021 before it grew 20bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.09% in 2021, then crashed by -74bps to 0.15% in 2022, then increased by 13bps to 0.13% in 2023, then soared by 127bps to 0.03% in 2024, then plummeted by -221bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Return on Assets are 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025).